Alexandria Real Estate Equities
ARE
#2319
Rank
HK$61.18 B
Marketcap
HK$354.04
Share price
-2.38%
Change (1 day)
-54.83%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -HK$0.17 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are HK$2.97 Billion. In 2024 the company made an earning of HK$5.42 Billion, an increase over its 2023 earnings that were of HK$2.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.17 Billion-103.01%
2024 HK$5.42 B96.11%
2023 HK$2.76 B-53.56%
2022 HK$5.95 B-3.96%
2021 HK$6.20 B-20.26%
2020 HK$7.77 B72.88%
2019 HK$4.49 B3.11%
2018 HK$4.36 B73.54%
2017 HK$2.51 B464.88%
2016 HK$0.44 B-77.32%
2015 HK$1.96 B36.31%
2014 HK$1.43 B-10.81%
2013 HK$1.61 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.26 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$76.95 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.18 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$7.74 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.17 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$1.01 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA